Catalyst Wire Dossier Catalyst Wire Dossier

QTI571

QTI571 · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QTI571, covering 2019-06-18 to 2021-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants [Phase 3]

See pricing